在脂肪组织内以虹膜剂为媒介的信号通路中的微RNA动态
Ming-Yun Ho1, Kai-Pin Chiu, Ming-Lung Tsai
1Division of Cardiology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
Journal of biosciences
|October 8, 2024
概括
虹膜素通过影响涉及能量平衡和胰岛素敏感性的特定微RNA (miRNAs) 来调节脂肪组织代谢. 这项研究确定了miRNA-758和miRNA-668作为素的关键调节剂.
科学领域:
- 分子内分泌学分子内分泌学
- 脂肪组织生物学 脂肪组织生物学
- 微RNA治疗药物 微RNA治疗药物
背景情况:
- 虹膜在调节脂肪组织新陈代谢方面发挥着至关重要的作用,影响能量平衡和胰岛素敏感性.
- 了解分子通路,特别是微RNA (miRNA) 介导的信号传递,对于开发对抗肥胖和代谢障碍的策略至关重要.
研究的目的:
- 通过使用全面的miRNA转录基因方法,研究虹膜素对脂肪组织基因表达的影响.
- 确定由素调节的特定miRNA,并阐明它们在关键信号通路中的作用.
主要方法:
- 利用miRNA转录组分析,在暴露于虹膜素后,在脂肪细胞和小鼠白脂肪组织中识别出差异表达的miRNA.
- 进行信号通路和网络分析,以确定已识别的miRNAs的功能作用.
主要成果:
- 确定了两个关键的miRNAs,miRNA-758和miRNA-668,受到素的显著影响.
- 证明了miRNA-758和miRNA-668都在暴露于素后,在素和CDK5信号通路中起到关键调节者的作用.
结论:
- 虹膜素通过依赖于miRNA的调节瘦素和CDK5信号通路来调节脂肪组织代谢.
- 这些发现突出了参与素机制的特定miRNA和基因,为新型代谢疾病治疗策略提供了潜在的点.
更多相关视频
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
2.7K
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.0K
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
